42 Stocks Moving in Thursday's Pre-Market Session

Loading...
Loading...

Gainers

  • Vinco Ventures, Inc BBIG shares rose 225% to $5.01 in pre-market trading following a report of reverse merger. The company said on Jan 20, the company and Vinco Acquisition Corp entered into a deal with Zash Global Media and Entertainment Corp.
  • Addex Therapeutics Ltd ADXN shares rose 128% to $24.05 in pre-market trading after the company disclosed that its partner Janssen Pharmaceuticals, Inc received FDA’s Investigational New Drug (IND) approval to start a Phase 2a clinical study in epilepsy.
  • Medley Management Inc. MDLY shares rose 51.3% to $14.18 in pre-market trading after board member Jeffrey B. Tonkel disclosed a 6% passive stake in the company.
  • Celsion Corporation CLSN shares rose 41.2% to $1.80 in pre-market trading after jumping 40% on Wednesday.
  • Qutoutiao Inc. QTT rose 37.5% to $3.70 in pre-market trading after gaining 13% on Wednesday.
  • Precision BioSciences, Inc. DTIL shares rose 29% to $18.88 in pre-market trading. Precision BioSciences recently announced that the FDA accepted an IND for its PBCAR19B, a CAR T candidate for non-Hodgkin Lymphoma.
  • Titan Pharmaceuticals, Inc. TTNP rose 24.8% to $3.84 in pre-market trading. Titan Pharmaceuticals, last week, announced pricing of $9.7 million offering.
  • Jaguar Health, Inc. JAGX rose 22.3% to $3.57 in pre-market trading after declining 11% on Wednesday. Jaguar Health, last week, announced it entered a binding agreement of terms for $6.0 million for the sale of partial rights to a possible tropical disease priority review voucher.
  • electroCore, Inc. ECOR rose 19.4% to $2.96 in pre-market trading after jumping over 30% on Wednesday. ElectroCore recently announced the establishment of unique Level II HCPCS code for 'non-invasive vagus nerve stimulator.'
  • Caladrius Biosciences, Inc. CLBS rose 19.3% to $3.45 in pre-market trading after jumping over 77% on Wednesday. Caladrius Biosciences, on Tuesday, said it treated first patient in Phase 2b FREEDOM trial of CLBS16 for the treatment of coronary microvascular dysfunction.
  • Brickell Biotech, Inc. BBI rose 18.6% to $1.34 in pre-market trading. Brickell Biotech recently announced the publication of Japan pivotal Phase 3 study results for sofpironium bromide gel, 5% in the Journal of Dermatology.
  • Lipocine Inc.. LPCN rose 17.9% to $2.44 in pre-market trading after jumping around 18% on Wednesday.
  • Tengasco, Inc. TGC rose 17.3% to $2.10 in pre-market trading after climbing 26% on Wednesday.
  • Acasti Pharma Inc. ACST shares rose 16% to $0.8768 in pre-market trading after surging over 18% on Wednesday.
  • Iterum Therapeutics plc ITRM rose 15.5% to $2.01 in pre-market trading after jumping around 33% on Wednesday.
  • ENDRA Life Sciences Inc. NDRA rose 15.2% to $2.35 in pre-market trading after climbing 17% on Wednesday. ENDRA Life Sciences, last week, was granted 13th US patent for its Taeus platform technology.
  • Lineage Cell Therapeutics, Inc.. LCTX rose 14% to $3.42 in pre-market trading as the company announced resignation of its CFO.
  • OncoCyte Corp OCX rose 13.6% to $4.68 in pre-market trading after the company announced it entered into definitive agreements with its two largest institutional investors to purchase approximately $25 million of its common shares in a registered offering at $3.424 per share.
  • Motus GI Holdings, Inc. MOTS rose 13.5% to $1.93 in pre-market trading. Motus GI Holdings received a letter from Nasdaq notifying the company regained compliance.
  • InspireMD, Inc. NSPR shares rose 12.6% to $0.7990 in pre-market trading after gaining around 15% on Wednesday.
  • Titan Medical Inc. TMDI rose 12.6% to $3.21 in pre-market trading after jumping 52% on Wednesday.
  • Atossa Therapeutics, Inc. ATOS shares rose 12.5% to $1.73 in pre-market trading after jumping over 9% on Wednesday.
  • BIOLASE, Inc. BIOL shares rose 12.2% to $1.08 in pre-market trading. Biolase, last week, announced an agreement with DSO Dental Care to 'expand laser adoption and hands-on training programs in targeted geographies.'.
  • ReWalk Robotics Ltd.. RWLK rose 11.5% to $2.23 in pre-market trading after gaining over 8% on Wednesday.
  • Cardiff Oncology, Inc. CRDF rose 10.7% to $12.33 in pre-market trading. Cardiff Oncology, last week, announced the presentation of data from its Phase 1b/2 study in KRAS-mutated metastatic colorectal cancer as part of the American Society of Clinical Oncology Gastrointestinal Cancers Symposium.
  • Gevo, Inc. GEVO rose 10.4% to $9.57 in pre-market trading. Gevo shares dipped over 21% on Wednesday after the company announced a $350 million registered direct offering of common stock.
  • Sonim Technologies Inc SONM rose 9.5% to $0.92 in pre-market trading after the company announced it received an extension from Nasdaq to regain compliance.
  • Insteel Industries Inc IIIN rose 8.4% to $28.35 in pre-market trading after reporting upbeat Q1 results.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Obalon Therapeutics, Inc. OBLN fell 20.5% to $6.58 in pre-market trading. Obalon Therapeutics shares jumped over 414% on Wednesday after the company announced a merger agreement with ReShape Lifesciences.
  • Steel Connect, Inc. STCN shares fell 16.3% to $2.23 in pre-market trading after surging 79% on Wednesday.
  • Foresight Autonomous Holdings Ltd. FRSX fell 13.3% to $7.99 in pre-market trading after declining around 8% on Wednesday.
  • Gritstone Oncology, Inc. GRTS fell 11.9% to $22.47 in pre-market trading. Gritstone Oncology shares jumped over 14% on Wednesday after the company announced an agreement with Genevant to obtain a nonexclusive license to Genevant's LNP technology to develop and commercialize self-amplifying RNA vaccines against COVID-19.
  • Cancer Genetics, Inc. CGIX fell 11.1% to $5.21 in pre-market trading after jumping around 75% on Wednesday.
  • Adamis Pharmaceuticals Corporation ADMP shares fell 10.4% to $1.28 in pre-market trading. Adamis Pharmaceuticals shares climbed around 78% on Wednesday after the company announced the submission of an Investigational New Drug to FDA for the investigational use of Tempol for the treatment of Coronavirus.
  • Marathon Patent Group, Inc.. MARA fell 9.5% to $17.43 in pre-market trading after declining around 14% on Wednesday.
  • Avinger, Inc. AVGR fell 8.7% to $2.10 in pre-market trading after surging 17% on Wednesday. The company last week initiated the commercial launch of its Tigereye image-guided chronic total occlusion crossing system.
  • Riot Blockchain, Inc. RIOT fell 8.5% to $20.40 in pre-market trading after dropping over 11% on Wednesday.
  • CytomX Therapeutics, Inc. CTMX fell 7.4% to $7.55 in pre-market trading after the company reported pricing of $100 million public offering of common stock.
  • Urban Tea, Inc. MYT shares fell 7.2% to $2.06 in pre-market trading after gaining over 19% on Wednesday.
  • Inovio Pharmaceuticals Inc INO fell 5.9% to $9.15 in pre-market trading after the company priced its 17.7 million share public offering of common stock at $8.50 per share. The co.'s 8-K shows its planned clinical development on its potential COVID-19 vaccine has been placed on partial clinical hold by the FDA.
  • OncoSec Medical Inc. ONCS fell 5.8% to $5.43 in pre-market trading after the company reported an offering of common stock.
  • Orchid Island Capital Inc ORC fell 4% to $5.31 in pre-market trading after the company announced a 7.6 million share common stock offering.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...